Citation Impact
Citing Papers
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M
2012
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Surrogate threshold effect: an alternative measure for meta‐analytic surrogate endpoint validation
2006
Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome
2018
A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects
2005
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
2009 Standout
Diabetic retinopathy
2010 Standout
ESPEN guideline on clinical nutrition in the intensive care unit
2018 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Marine natural products
1990 Standout
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412
2002
Cancer drug resistance: an evolving paradigm
2013 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
2018
Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes*
2003
IgE and mast cells in allergic disease
2012 Standout
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
1989
C‐Reactive Protein (CRP)‐Lowering Agents
2006
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
Immunology and immunotherapy of colorectal cancer
2003
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
1999
Cancer genes and the pathways they control
2004 Standout
Diabetes in Asia
2009 Standout
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
2005
Protective Effect of Fish Oil Supplementation on Exercise-Induced Bronchoconstriction in Asthma
2006
Fish Intake, Contaminants, and Human Health
2006 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Overview of the clinical efficacy of investigational anticancer drugs
2003
Oxidative Stress in Cancer
2020 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Dose‐ and Time‐Dependent Pharmacokinetics of Midostaurin in Patients With Diabetes Mellitus
2008
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Meta-analysis when only the median survival times are known: A comparison with individual patient data results
2005
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Risk of dementia in diabetes mellitus: a systematic review
2005 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
1998
Stroke in patients with diabetes mellitus
2004
Sarcoidosis
2007 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Anemia of Chronic Disease
2005 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
2005
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Spectrum of Activity and Mechanism of Action of VEGF/PDGF Inhibitors
2007
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice
2005
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3
2004
Acute Myeloid Leukemia and Acute Promyelocytic Leukemia
2003
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases
2002
Structural and Biochemical Studies of a Fluoroacetyl-CoA-Specific Thioesterase Reveal a Molecular Basis for Fluorine Selectivity
2010 StandoutNobel
Diabetic Retinopathy and Diabetic Macular Edema
2003
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412
2004
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Metabolic Syndrome
2008 Standout
Diabetic Retinopathy
2004
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival
2005
Selected Novel Anticancer Treatments Targeting Cell Signaling Proteins
2001
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
New Indolocarbazoles from a Mutant Strain of the Marine-Derived Actinomycete Streptomyces fradiae 007M135
2012
Works of A. Man being referenced
Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.
1985
Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer
2001
Eosinophil influx into the airways in patients with exercise-induced asthma
2000
Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
1996
Prevention or Treatment of Ards With Aspirin
2016
Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease
1999
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial
2005
Vitamin C revisited
2014
Vitamin C Pharmacokinetics in Critically Ill Patients
2018
Rapid Progression of Albumin Excretion Is an Independent Predictor of Cardiovascular Mortality in Patients With Type 2 Diabetes and Microalbuminuria
2001
Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C
2001